TAMSULOSIN HCL TEVA 0,4 MG TBL PRO 30

What is the maximum co-payment for TAMSULOSIN HCL TEVA?

If the insurance company contributes, the maximum co-payment is 114,19 Kč. The maximum pharmacy price is 159,87 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does TAMSULOSIN HCL TEVA have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

45,68 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe TAMSULOSIN HCL TEVA?

Prescription is not conditional on a medical specialization.

What is the composition of TAMSULOSIN HCL TEVA?

Tamsulosin-hydrochlorid (0,4 mg), tamsulosin (0,367 mg), neznámá látka s kódem 3755, neznámá látka s kódem 14769, koloidní bezvodý oxid křemičitý, magnesium-stearát, neznámá látka s kódem 18805. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to TAMSULOSIN HCL TEVA?

The medicine belongs to ATC group G04CA02 – TAMSULOSIN. Medicines with the same active substance can be found here.

Who manufactures TAMSULOSIN HCL TEVA?

Teva Pharmaceuticals CR, s.r.o., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 28. 8. 2023. Production was terminated with effect from 28. 8. 2023. The manufacturer lists medicines with the following code as a potential substitute: